The Economic Burden of Epilepsy in Korea, 2010
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Objectives: The purposes of this study were to evaluate the prevalence of epilepsy and to estimate the cost of epilepsy in Korea, 2010. Methods: This study used a prevalence based approach to calculate the cost of epilepsy. Claims data from the Korean national health insurance and data from the Korea health panel, the Korea National Statistical Office’s records of causes of death, and labor statistics were used to estimate the cost of epilepsy. Patients were defined as those who were hospitalized or visited an outpatient clinic during 2010 with a diagnosis of epilepsy (International Classification of Diseases 10th revision codes G40-G41). Total costs of epilepsy included direct medical costs, direct non-medical cost and indirect costs. Results: The annual prevalence of treated epilepsy was 228 per 100 000 population, and higher in men. The age-specific prevalence was highest for teenagers. The total economic burden of epilepsy was 536 billion Korean won (KW). Indirect cost (304 billion KW) was 1.3 times greater than direct cost (232 billion KW). By gender, the male (347 billion KW) were more burdened than the female (189 billion KW). The estimated cost in young age younger than 20 years old was 24.5% of the total burden of epilepsy. Conclusions: A significant portion of the economic burden of epilepsy is borne by people in young age. To reduce the economic burden of epilepsy, effective prevention and treatment strategies are needed.
Abstract
Objectives: The purposes of this study were to evaluate the prevalence of epilepsy and to estimate the cost of epilepsy in Korea, 2010. Methods: This study used a prevalence based approach to calculate the cost of epilepsy. Claims data from the Korean national health insurance and data from the Korea health panel, the Korea National Statistical Office’s records of causes of death, and labor statistics were used to estimate the cost of epilepsy. Patients were defined as those who were hospitalized or visited an outpatient clinic during 2010 with a diagnosis of epilepsy (International Classification of Diseases 10th revision codes G40-G41). Total costs of epilepsy included direct medical costs, direct non-medical cost and indirect costs. Results: The annual prevalence of treated epilepsy was 228 per 100 000 population, and higher in men. The age-specific prevalence was highest for teenagers. The total economic burden of epilepsy was 536 billion Korean won (KW). Indirect cost (304 billion KW) was 1.3 times greater than direct cost (232 billion KW). By gender, the male (347 billion KW) were more burdened than the female (189 billion KW). The estimated cost in young age younger than 20 years old was 24.5% of the total burden of epilepsy. Conclusions: A significant portion of the economic burden of epilepsy is borne by people in young age. To reduce the economic burden of epilepsy, effective prevention and treatment strategies are needed.
참고문헌 (31)
- Fisher RS, "Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)", Epilepsia, 46(4), pp.470~472 (2005)
- Sridharan R, "Epidemiology of epilepsy", Curr Sci, 82(6), pp.664~670 (2002)
- De Boer HM, "The global burden and stigma of epilepsy", Epilepsy Behav, 12(4), pp.540~546 (2008)
- Banerjee PN, "The descriptive epidemiology of epilepsy-a review", Epilepsy Res, 85(1), pp.31~45 (2009)
- Sander JW, "The epidemiology of epilepsy revisited", Curr Opin Neurol, 16(2), pp.165~170 (2003)
- Gaitatzis A, "The psychiatric comorbidity of epilepsy", Acta Neurol Scand, 110(4), pp.207~220 (2004)
- Yoon D, "Economic impact of epilepsy in the United States", Epilepsia, 50(10), pp.2186~2191 (2009)
- Pugliatti M, "Estimating the cost of epilepsy in Europe: a review with economic modeling", Epilepsia, 48(12), pp.2224~2233 (2007)
- 이서영, "Prevalence of Treated Epilepsy in Korea Based on National Health Insurance Data", Journal of Korean Medical Science, 27(3), pp.285~290 (2012), 대한의학회
- Murray CJ, "Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study", Lancet, 349(9063), pp.1436~1442 (1997)
- Stat NC, "Healthy people 2000 review, 1995-1996", pp.1~3 (1996), Public Health Service
- Results of survey on medical care cost by patient in Survey on the Benefit Coverage Rate of National Health Insurance in 2010, "Park JM", National Health Insurance Corporation, 136~138 (2011)
- "The Korea Health Panel Survey"[URL]
- Korean Guardian Association, "The official averaged guardian cost", Korean Guardian Association, 3~5 (2008)
- "2008 The survey report on labor conditions by employment type"[URL]
- "Korean Statistical System 2010"[URL]
- "ICD-10: international statistical classification of diseases and related health problems"[URL]
- Jeong YH, "An estimation of economic costs of 5 major diseases", Health Welf Policy Forum, 79, pp.55~65 (2003)
- Engel J Jr, "A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology", Epilepsia, 42(6), pp.796~803 (2001)
- Hauser WA, "Prevalence of epilepsy in Rochester, Minnesota: 1940-1980", Epilepsia, 32(4), pp.429~445 (1991)
- Forsgren L, "Prevalence of epilepsy in adults in northern Sweden", Epilepsia, 33(3), pp.450~458 (1992)
- Forsgren L, "The epidemiology of epilepsy in Europe: a systematic review", Eur J Neurol, 12(4), pp.245~253 (2005)
- Trinka E, "Causes of status epilepticus", Epilepsia, 53(4), pp.127~138 (2012)
- Vezzani A, "Inflammation and epilepsy", Handb Clin Neurol, 107, pp.163~175 (2012)
- Besocke AG, "Outcome of newly-diagnosed epilepsy in older patients", Epilepsy Behav, 27(1), pp.29~35 (2013)
- 김현진, "The economic burden of stroke in 2010 in Korea", 대한의사협회지, 55(12), pp.1226~1236 (2012), 대한의사협회
- Lee YH, "Economic burden of asthma in Korea", Allergy Asthma Proc, 32(6), pp.35~40 (2011)
- Kim SY, "Economic burden of allergic rhinitis in Korea", Am J Rhinol Allergy, 24(5), pp.110~e113 (2010)
- Strzelczyk A, "Cost of epilepsy: a systematic review", Pharmacoeconomics, 26(6), pp.463~476 (2008)
- King JT Jr, "A cost-effectiveness analysis of anterior temporal lobectomy for intractable temporal lobe epilepsy", J Neurosurg, 87(1), pp.20~28 (1997)
- Langfitt JT, "Health care costs decline after successful epilepsy surgery", Neurology, 68(16), pp.1290~1298 (2007)